SBRT+TACE+Sorafenib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SBRT+TACE+Sorafenib, covering 2023-02-16 to 2023-02-16. Get the full timeline:
Most recent: Clinical Trial Update: SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT [Phase 3]